TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Cross-Sectional Studies
KW - Drug Overdose/prevention & control
KW - Health Services Accessibility/statistics & numerical data
KW - Humans
KW - naloxone
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Ohio
KW - opioid overdose
KW - Opioid-Related Disorders/drug therapy
KW - prevention
KW - Program Development/statistics & numerical data
KW - Program Evaluation
AU - E. L. Winstanley
AU - A. Clark
AU - J. Feinberg
AU - C. M. Wilder
A1 - 
AB - BACKGROUND: Nationally, overdose fatalities have reached epidemic proportions. Ohio has one of the highest overdose death rates in the country, as well as high rates of prescription opioid trafficking. METHODS: A cross-sectional self-report survey of opioid overdose prevention programs (OOPPs) in Ohio was conducted between August and October 2014 to characterize programs and ascertain barriers to successful implementation. A 91% response rate was achieved with 18 programs participating in the study. RESULTS: The first Ohio OOPP opened in August 2012, a second program opened in 2013, and the remaining programs began in 2014. All of the programs distribute nasal naloxone and provide overdose prevention education, and 89% (n = 16) provide overdose kits for free. Six OOPPs are funded by the Ohio Department of Health, 3 programs are funded by a local health foundation, and several other public and private funding sources were reported. The OOPPs have funding to distribute a combined total of 8,670 overdose kits and had distributed 1998 kits by October 2014. The OOPPs reported 149 overdose reversals. Fifteen programs (83%) reported implementation barriers that were categorized as stigma-, cost-, staffing-, legal, regulatory, and client-related problems. Legislative changes aimed at removing some of the obstacles to distribution and lay administration of naloxone have recently been enacted in Ohio. CONCLUSIONS: OOPPs have rapidly expanded in Ohio during the past 3 years. Although recent legislative changes have addressed some of the reported implementation barriers, stigma and the cost of naloxone remain significant problems.
BT - Substance abuse
C5 - Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1080/08897077.2015.1132294
IS - 1
JF - Substance abuse
N2 - BACKGROUND: Nationally, overdose fatalities have reached epidemic proportions. Ohio has one of the highest overdose death rates in the country, as well as high rates of prescription opioid trafficking. METHODS: A cross-sectional self-report survey of opioid overdose prevention programs (OOPPs) in Ohio was conducted between August and October 2014 to characterize programs and ascertain barriers to successful implementation. A 91% response rate was achieved with 18 programs participating in the study. RESULTS: The first Ohio OOPP opened in August 2012, a second program opened in 2013, and the remaining programs began in 2014. All of the programs distribute nasal naloxone and provide overdose prevention education, and 89% (n = 16) provide overdose kits for free. Six OOPPs are funded by the Ohio Department of Health, 3 programs are funded by a local health foundation, and several other public and private funding sources were reported. The OOPPs have funding to distribute a combined total of 8,670 overdose kits and had distributed 1998 kits by October 2014. The OOPPs reported 149 overdose reversals. Fifteen programs (83%) reported implementation barriers that were categorized as stigma-, cost-, staffing-, legal, regulatory, and client-related problems. Legislative changes aimed at removing some of the obstacles to distribution and lay administration of naloxone have recently been enacted in Ohio. CONCLUSIONS: OOPPs have rapidly expanded in Ohio during the past 3 years. Although recent legislative changes have addressed some of the reported implementation barriers, stigma and the cost of naloxone remain significant problems.
PP - United States
PY - 2016
SN - 1547-0164; 0889-7077
SP - 42
EP - 46
EP - 
T1 - Barriers to implementation of opioid overdose prevention programs in Ohio
T2 - Substance abuse
TI - Barriers to implementation of opioid overdose prevention programs in Ohio
U1 - Opioids & Substance Use
U2 - 26682929
U3 - 10.1080/08897077.2015.1132294
VL - 37
VO - 1547-0164; 0889-7077
Y1 - 2016
ER -